Valneva SE VALN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:21 AM EST
13.62quote price arrow down-0.67 (-4.69%)
Volume
8,726
52 week range
9.77 - 40.70
Loading...
  • Open13.75
  • Day High13.84
  • Day Low13.55
  • Prev Close14.29
  • 52 Week High40.70
  • 52 Week High Date04/14/22
  • 52 Week Low9.77
  • 52 Week Low Date09/29/22

Key Stats

  • Market Cap834.05M
  • Shares Out117.28M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change7.31

KEY STATS

  • Open13.75
  • Day High13.84
  • Day Low13.55
  • Prev Close14.29
  • 52 Week High40.70
  • 52 Week High Date04/14/22
  • 52 Week Low9.77
  • 52 Week Low Date09/29/22
  • Market Cap834.05M
  • Shares Out117.28M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change7.31

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Valneva SE

 

Profile

MORE
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli...
Perry Celentano
Chief Operating Officer
Peter Buhler
Chief Financial Officer, Member of the Management Board
Frederic Jacotot
Member of the Management Board, General Counsel, Corporate Secretary
Joshua Drumm
Vice President - Investor Relations
Address
6 rue Alain Bombard
Saint-herblain
44800
France